SCHEMBL797544

SCHEMBL797544

C1CNNCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2670598 1.00 HIF1A (0.67)
SCHEMBL28526434 1.00 HIF1A (0.67)
SCHEMBL6100699 1.00 HIF1A (0.67)
Hydrochloric Acid SCHEMBL5564783 0.95 HIF1A (0.60)
SCHEMBL1894089 0.83 CXCR4 (0.57)
SCHEMBL20523496 0.83
SCHEMBL23895059 0.82
Piperazine SCHEMBL734764 0.82 HIF1A (1.00)
SCHEMBL3999265 0.82 HIF1A (1.00)
SCHEMBL5033222 0.82 HIF1A (1.00)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116813617-B Fluorescent probe based on naphthalimide-1, 4, 7-triazepan, preparation method and application thereof 江汉大学 2025-01-21 CN claimed
CN-116813617-A Fluorescent probe based on naphthalimide-1, 4, 7-triazepan, preparation method and application thereof 江汉大学 2023-09-29 CN claimed
EP-4653419-A1 LINKER FOR ANTIBODY-DRUG CONJUGATES, AND ANTIBODY-DRUG CONJUGATE Otsuka Pharmaceutical Co., Ltd. (JP) 2025-11-26 EP disclosed
US-20250059191-A1 CRYSTALLINE FORMS OF DIAZABICYCLOOCTANE DERIVATIVE AND PRODUCTION PROCESS THEREOF MEIJI SEIKA PHARMA CO., LTD. (JP) 2025-02-20 US disclosed
US-12221443-B2 Crystalline forms of diazabicyclooctane derivative and production process thereof MEIJI SEIKA PHARMA CO., LTD. (JP) 2025-02-11 US disclosed
CN-116813617-B Fluorescent probe based on naphthalimide-1, 4, 7-triazepan, preparation method and application thereof 江汉大学 2025-01-21 CN disclosed
CN-116813617-B Fluorescent probe based on naphthalimide-1, 4, 7-triazepan, preparation method and application thereof 江汉大学 2025-01-21 CN disclosed
CN-116813617-B Fluorescent probe based on naphthalimide-1, 4, 7-triazepan, preparation method and application thereof 江汉大学 2025-01-21 CN disclosed
US-12103928-B2 Processes for preparing a diazabicyclooctane compound MEIJI SEIKA PHARMA CO., LTD. (JP) 2024-10-01 US disclosed
WO-2024154763-A1 LINKER FOR ANTIBODY-DRUG CONJUGATES, AND ANTIBODY-DRUG CONJUGATE 大塚製薬株式会社 2024-07-25 WO disclosed
US-12012467-B2 Small molecule DCN1 inhibitors and therapeutic methods using the same REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2024-06-18 US disclosed
US-20060128568-A1 3-cyclopropyl-4-(3-amino-2-methylbenzoyl)pyrazoles and their use as herbicides BAYER CROPSCIENCE GMBH (DE) 2006-06-15 US disclosed
WO-2006061074-A1 3-CYCLOPROPYL-4-(3-AMINO-2-METHYLBENZOYL)PYRAZOLS AND THE USE OF THE SAME AS HERBICIDES BAYER CROPSCIENCE AG (DE) 2006-06-15 WO disclosed
US-20040033891-A1 Cationic group-3 catalyst system EXXONMOBIL CHEMICAL PATENTS INC. 2004-02-19 US disclosed
US-20040024234-A1 Cationic catalyst system EXXONMOBIL CHEMICAL PATENTS INC. 2004-02-05 US disclosed
EP-1355736-A2 CATIONIC CATALYST SYSTEM ExxonMobil Chemical Patents Inc. (US) 2003-10-29 EP disclosed
EP-1337536-A1 CATIONIC GROUP-3 CATALYST SYSTEM ExxonMobil Chemical Patents Inc. (US) 2003-08-27 EP disclosed
WO-2002059157-A2 CATIONIC CATALYST SYSTEM EXXONMOBIL CHEMICAL PATENTS INC. (US) 2002-08-01 WO disclosed
WO-2002032909-A1 CATIONIC GROUP-3 CATALYST SYSTEM EXXONMOBIL CHEMICAL PATENTS INC. (US) 2002-04-25 WO disclosed
US-4801706-A ANTIARRHYTHMIA HYPOTENSIVE AMERICAN HOME PRODUCTS CORPORATION (US) 1989-01-31 US disclosed